by Admin | Jan 28, 2020 | Portfolio News
CHENGDU, China – 28 January 2020 – Clover Biopharmaceuticals, a global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, today announced that it has initiated development of a recombinant subunit vaccine for...
by Admin | Jan 10, 2020 | Portfolio News
San Francisco, California, January 10, 2020 – Thermalin Inc., a privately held biotechnology company with its main laboratories in Cleveland, Ohio today announced the completion of a working prototype system for its StampPump, a postage-stamp-sized glucose management...
by Admin | Jan 10, 2020 | Portfolio News
CHENGDU, China–(BUSINESS WIRE)–Clover Biopharmaceuticals, a global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, today announced that the first patient was dosed in another Phase I trial of SCB-313,...
by Admin | Jan 10, 2020 | Portfolio News
January 10, 2020 10:00 AM Eastern Standard Time CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc., a company singularly dedicated to addressing unsolved problems in stroke, today announced that Daniel Davis has been appointed as the company’s Chief...
by Admin | Jan 9, 2020 | Portfolio News
January 09, 2020 09:00 AM Eastern Standard Time PHOENIX–(BUSINESS WIRE)–OncoMyx Therapeutics, a privately-held oncolytic immunotherapy company, announced today the formation of its Scientific Advisory Board (SAB), comprised of experts in tumor immunology,...
by Admin | Dec 30, 2019 | Portfolio News
BEIJING, China – 30 December 2019 – Clover Biopharmaceuticals, a global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, today announced that the first patient was dosed in a Phase III trial of SCB-808, a proposed...
by Admin | Dec 26, 2019 | Portfolio News
December 26, 2019 The Barricaid team is proud to be ranked among the top 20 private medtech companies to watch in 2020 by MDDI (Medical Device and Diagnostic Industry). To our mission, we stay committed to reducing needless suffering by ensuring Barricaid Annular...
by Admin | Dec 10, 2019 | Portfolio News
December 10, 2019 08:00 AM Eastern Standard Time CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced that it has completed the initial closing of a Series C financing of $85 million to support the commercial launch of the company’s...
by Admin | Dec 10, 2019 | Delos News
CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced that it has completed the initial closing of a Series C financing of $85 million to support the commercial launch of the company’s portfolio, which is composed of the latest advances in...
by Admin | Nov 27, 2019 | Delos News
CHENGDU, China–(BUSINESS WIRE)–Clover Biopharmaceuticals, a global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, today announced the completion of a US$ 43 million (RMB 304 million) Series B...
